All Actinic keratosis articles
-
Formulary decision guideKlisyri▼ (tirbanibulin) 10 mg/g ointment
This formulary decision guide was developed from content provided by Almirall Ltd in a format developed by Guidelines in Practice. It was commissioned by Almirall Ltd, who carried out full medical approval to ensure compliance with regulations.
View prescribing and adverse event reporting information
UK-KLI-2100017 | Date of preparation: October 2021 -
Implementing guidelines
Actinic keratosis: PCDS updates guidance on primary care management
Dr Kash Bhatti highlights recent updates to the PCDS pathway on actinic keratosis and considerations when assessing and managing this common condition
-
Implementing guidelines
Most actinic keratosis can be managed with topical treatments
Dr Neil Shroff explores updated British Association of Dermatologists guidance on actinic keratosis and offers an overview of treatment options and considerations
-
Top tips
Top tips: actinic keratosis
Dr Neil Shroff shares some key points for managing actinic keratoses in primary care
-
Implementing guidelines
More treatment choices for AK bring wider patient options
Dr Stephen Kownacki considers some newer treatments for actinic keratosis as reflected in the latest PCDS guideline and shows how therapies can be individualised
-
Implementing guidelines
Patient education and treatment options are key in actinic keratosis
Drs Neil Shroff (left) and Stephen Kownacki explore the clinical approaches to actinic keratosis and show how most patients can be treated and managed in primary care
-
Implementing guidelines
Many modalities of therapy are available for actinic keratoses
Dr David de Berker highlights the key recommendations from the guideline on management and treatment of AK, published by the British Association of Dermatologists
